Insider · CIK 0001711576

Walters-Hoffert Lisa

Reports to the SEC for 3 companies · ENCINITAS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001711576

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2026-05-28	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	—	—	94,107
2026-05-28	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2025-05-28	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitsA Award	Director	AAward	+50K sh	—	—	50,000
2025-04-18	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.1K sh	—	—	44,107
2025-04-18	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−17.1K sh	—	—	0
2025-04-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-08-19	KPRXKIORA PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,250 sh	$3.86	+$4,825	1,250
2024-07-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+1,778 sh	—	—	1,778
2024-04-29	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,526 sh	—	—	27,584
2024-04-29	FLUXFlux Power Holdings, Inc.S Sale	Director	SSale	−534 sh	$4.50	−$2,403	27,050
2024-04-29	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,526 sh	—	—	0
2024-04-22	FLUXFlux Power Holdings, Inc.S Sale	Director	SSale	−5,909 sh	$4.03	−$23.8K	26,058
2024-04-22	FLUXFlux Power Holdings, Inc.S Sale	Director	SSale	−5,909 sh	$4.03	−$23.8K	26,058
2024-04-20	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.9K sh	—	—	31,967
2024-04-20	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−16.9K sh	—	—	0
2024-04-20	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.9K sh	—	—	31,967
2024-04-20	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−16.9K sh	—	—	0
2024-04-18	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitA Award	Director	AAward	+17.1K sh	—	—	17,057
2024-04-18	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitA Award	Director	AAward	+17.1K sh	—	—	17,057
2023-09-25	FLUXFlux Power Holdings, Inc.S Sale	Director	SSale	−6,761 sh	$3.88	−$26.2K	15,084
2023-04-29	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,526 sh	—	—	21,845
2023-04-29	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,526 sh	—	—	1,526
2023-04-28	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.8K sh	—	—	20,319
2023-04-28	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−17.8K sh	—	—	0
2023-04-20	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitA Award	Director	AAward	+16.9K sh	—	—	16,883
2023-03-07	FLUXFlux Power Holdings, Inc.P Purchase	Director	PPurchase	+1,000 sh	$6.36	+$6,360.6	2,526
2023-01-24	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+290K sh	—	—	290,000
2022-04-29	FLUXFlux Power Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,526 sh	—	—	1,526
2022-04-29	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,526 sh	—	—	3,052
2022-04-28	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitsA Award	Director	AAward	+17.8K sh	—	—	17,793
2022-01-25	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+185K sh	—	—	185,000
2021-04-29	FLUXFlux Power Holdings, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,578 sh	—	—	4,578
2021-01-26	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+168K sh	—	—	168,000
2020-03-06	DAREDare Bioscience, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+68K sh	—	—	68,000
2020-01-01	FLUXFlux Power Holdings, Inc. · Stock OptionA Award	Director	AAward	+3,948 sh	—	—	3,948
2019-01-29	DAREDare Bioscience, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2018-09-07	DAREDare Bioscience, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2017-07-19	DAREDare Bioscience, Inc.A Award	Chief Financial Officer	AAward	+444K sh	—	—	443,512

Recent filings

Accepted (ET)
Jun 124
Walters-Hoffert Lisa0001711576-26-000002
SEC(opens sec.gov)
Jun 14
Walters-Hoffert Lisa0001493152-26-026715
SEC(opens sec.gov)
Apr 214
Walters-Hoffert Lisa0001641172-25-005544
SEC(opens sec.gov)
Apr 24
Walters-Hoffert Lisa0001372514-25-000025
SEC(opens sec.gov)
Aug 204
Walters-Hoffert Lisa0001372514-24-000111
SEC(opens sec.gov)
Jul 34
Walters-Hoffert Lisa0001372514-24-000090
SEC(opens sec.gov)
Apr 304/A
Walters-Hoffert Lisa0001493152-24-017314
SEC(opens sec.gov)
Apr 304
Walters-Hoffert Lisa0001493152-24-017310
SEC(opens sec.gov)
Apr 224
Walters-Hoffert Lisa0001493152-24-015623
SEC(opens sec.gov)

Companies

Address

C/O KIORA PHARMACEUTICALS, INC. 169 SAXONY RD., SUITE 212

ENCINITAS, CA, 92024